Lenire ®.

Panakès Partners is a Financial backing company, based in Milan, which purchases one of the most ambitious firms and teams, establishing revolutionary innovations and items, in the field of life sciences, intending to enhance the lives of individuals around the world.

Established in 2010 by Dr. Ross 'Neill, CHIEF EXECUTIVE OFFICER, Neuromod Devices is a medical modern technology company that specialises in the design and advancement of neuromodulation innovations to attend to the medical needs of underserved client populations that deal with incapacitating and persistent conditions.

Because the previous round of funding raised in October 2020, the firm has made progress commercialising Lenire, broadening the device's availability throughout Europe, developing an entirely owned United States subsidiary, neuromod Devices wirbt 30 millionen euro ein U.S.A. Inc, and protecting US market authorization from the FDA.

The current financing - which greater than increases the money the NUI Maynooth spin-out has increased since it was founded in 2010 - is split uniformly between endeavor debt funding from the European Investment Bank and new equity investment.